Ensign Peak Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-248,394
Closed -$4.17M 1726
2025
Q2
$4.17M Sell
248,394
-41,321
-14% -$728K 0.01% 683
2025
Q1
$5.11M Sell
289,715
-20,532
-7% -$412K 0.01% 632
2024
Q4
$7.54M Sell
310,247
-218,949
-41% -$6.25M 0.01% 544
2024
Q3
$19.7M Sell
529,196
-22
-0% -$820 0.03% 331
2024
Q2
$25.2M Sell
529,218
-7,402
-1% -$324K 0.05% 270
2024
Q1
$20.5M Buy
536,620
+108,686
+25% +$3.53M 0.04% 319
2023
Q4
$13.4M Sell
427,934
-30,496
-7% -$1.1M 0.03% 369
2023
Q3
$18.4M Sell
458,430
-171
-0% -$8.01K 0.04% 280
2023
Q2
$24.1M Buy
458,601
+12,084
+3% +$736K 0.05% 264
2023
Q1
$28.6M Sell
446,517
-193,437
-30% -$12.6M 0.06% 238
2022
Q4
$31.1M Buy
639,954
+1,160
+0.2% +$72.8K 0.07% 231
2022
Q3
$45.1M Sell
638,794
-14,686
-2% -$1.26M 0.11% 172
2022
Q2
$46.4M Buy
653,480
+51,745
+9% +$3.33M 0.11% 168
2022
Q1
$48.1M Sell
601,735
-174,363
-22% -$13M 0.1% 179
2021
Q4
$70.9M Sell
776,098
-78,140
-9% -$8.38M 0.14% 140
2021
Q3
$110M Sell
854,238
-24,522
-3% -$3.43M 0.23% 108
2021
Q2
$134M Buy
878,760
+147,700
+20% +$19.5M 0.27% 97
2021
Q1
$77.1M Buy
731,060
+51,520
+8% +$5.16M 0.17% 125
2020
Q4
$53.8M Sell
679,540
-46,940
-6% -$3.43M 0.12% 152
2020
Q3
$41.1M Sell
726,480
-10,126
-1% -$545K 0.1% 165
2020
Q2
$45.3M Sell
736,606
-80,517
-10% -$3.29M 0.12% 140
2020
Q1
$26.4M Buy
817,123
+28,295
+4% +$954K 0.09% 177
2019
Q4
$27.7M Buy
+788,828
New +$26M 0.07% 237

Other funds holding STAA

Ensign Peak Advisors's STAA Position: Q3 2025 in Review

Ensign Peak Advisors sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 248,394 shares — an estimated $4.17M sold.

Ensign Peak Advisors first reported a position in STAA in Q4 2019 and held it in 23 quarters. The position peaked at $134M in Q2 2021. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

  • Ensign Peak Advisors reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 248,394 STAAR Surgical shares in Q3 2025, an estimated $4.17M.
  • Ensign Peak Advisors first reported a position in STAAR Surgical in Q4 2019 and held it in 23 quarters.
  • Ensign Peak Advisors's STAAR Surgical position peaked at $134M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on Ensign Peak Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.